$KRRO
Korro Bio, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, MA
KRRO chart
What traders are saying about $KRRO
Latest postsKorro Bio, Inc. news
- Form 4 Korro Bio Inc: Lynx1 Capital Management LP (10% Owner) For: 22 October
Investing.com Nigeria ·
- Korro Bio: 10% owner Lynx1 Capital Management LP buys $884,751 stock
Investing.com ·
- Across three dates, Lynx1 Master Fund buys 79,809 Korro Bio (KRRO) shares.
Stock Titan ·
- H.C. Wainwright Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $15
Moomoo ·
- Korro Bio, Inc. Estimates – NASDAQ:KRRO
TradingView ·
- Korro Bio, Inc. (KRRO) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Korro Bio, Inc. (KRRO) Surges 29.7%: Is This an Indication of Further Gains?
Yahoo Finance ·
- Form 8K Korro Bio Inc For: 22 October By Investing.com
Investing.com Nigeria ·
- Korro Bio reports preclinical data for AATD treatment KRRO-111
Investing.com ·
- Korro Bio Announces Preclinical Results for KRRO-111 Targeting Alpha-1 Antitrypsin Deficiency
Kalkine Media ·
- Korro Reports Best-in-Class Preclinical Data for KRRO-111 Demonstrating Potential to Benefit Lung and Liver Manifestations of Alpha-1 Antitrypsin Deficiency
Yahoo Finance ·
- Korro Bio management to meet virtually with Oppenheimer
TipRanks ·
Korro Bio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $6.4M | $2.3M | $0 | – |
| Net income | -$117.3M | -$83.6M | -$81.2M | -$58.0M |
| Diluted EPS | $-12.48 | $-9.37 | $-53.08 | $-227.42 |
| Total assets (year end) | $113.5M | $226.2M | $221.7M | $73.7M |
| Cash and equivalents (year end) | $21.8M | $55.6M | $166.2M | $36.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Korro Bio, Inc.
- Ticker
- KRRO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1703647
- Former names
- Frequency Therapeutics, Inc.
Frequently asked questions
What exchange is Korro Bio, Inc. listed on?
Korro Bio, Inc. trades on the Nasdaq under the ticker symbol KRRO.
What industry is Korro Bio, Inc. in?
Korro Bio, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Korro Bio, Inc. headquartered?
Korro Bio, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Korro Bio, Inc.'s fiscal year end?
Korro Bio, Inc.'s fiscal year ends on December 31.
How much revenue did Korro Bio, Inc. report?
Korro Bio, Inc. reported $6.4M in revenue for calendar year 2025, according to its SEC filings.